Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Veziris

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|November 30, 2016
Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in FranceFlorence Brossier, Anne Pham, Christine Bernard, et al.
Journal of Clinical Microbiology|April 8, 2016
Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex StrainsFlorence Brossier, David Guindo, Anne Pham, et al.
Emerging Infectious Diseases|August 10, 2017
Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant WomanMarie Jaspard, Elisabeth Elefant-Amoura, Isabelle Melonio, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymesAlexandra Aubry, Nicolas Veziris, Emmanuelle Cambau, et al.
BMC Infectious Diseases|June 3, 2014
Mycobacterial infection of breast prosthesis--a conservative treatment: a case reportDavid Atallah, Nadine El Kassis, George Araj, et al.
American Journal of Respiratory and Critical Care Medicine|October 25, 2008
A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosisNicolas Veziris, Murad Ibrahim, Nacer Lounis, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 7, 2012
Relapsing Mycobacterium genavense infection as a cause of late death in a lung transplant recipient: case report and review of the literatureElodie Lhuillier, Olivier Brugière, Nicolas Veziris, et al.
Respiration; International Review of Thoracic Diseases|December 7, 2021
Nontuberculous Mycobacteria under Scrutiny in the Geneva Area (2015-2020)Rechana Vongthilath-Moeung, Jérôme Plojoux, Antoine Poncet, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2010
Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencingSylvaine Bastian, Nicolas Veziris, Anne-Laure Roux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis RegimenLorenzo Guglielmetti, Wladimir Sougakoff, Thomas Maitre, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|November 30, 2016
Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in FranceFlorence Brossier, Anne Pham, Christine Bernard, et al.
Journal of Clinical Microbiology|April 8, 2016
Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex StrainsFlorence Brossier, David Guindo, Anne Pham, et al.
Emerging Infectious Diseases|August 10, 2017
Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant WomanMarie Jaspard, Elisabeth Elefant-Amoura, Isabelle Melonio, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymesAlexandra Aubry, Nicolas Veziris, Emmanuelle Cambau, et al.
BMC Infectious Diseases|June 3, 2014
Mycobacterial infection of breast prosthesis--a conservative treatment: a case reportDavid Atallah, Nadine El Kassis, George Araj, et al.
American Journal of Respiratory and Critical Care Medicine|October 25, 2008
A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosisNicolas Veziris, Murad Ibrahim, Nacer Lounis, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 7, 2012
Relapsing Mycobacterium genavense infection as a cause of late death in a lung transplant recipient: case report and review of the literatureElodie Lhuillier, Olivier Brugière, Nicolas Veziris, et al.
Respiration; International Review of Thoracic Diseases|December 7, 2021
Nontuberculous Mycobacteria under Scrutiny in the Geneva Area (2015-2020)Rechana Vongthilath-Moeung, Jérôme Plojoux, Antoine Poncet, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2010
Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencingSylvaine Bastian, Nicolas Veziris, Anne-Laure Roux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis RegimenLorenzo Guglielmetti, Wladimir Sougakoff, Thomas Maitre, et al.
Pageof 12